<?xml version="1.0" encoding="UTF-8"?>
<records>
<record>
<language>eng</language>
<publisher>Excellent Publishers</publisher>
<journalTitle>International Journal of Current Microbiology and Applied Sciences (IJCMAS) CODEN(USA)-IJCMO9</journalTitle>
<issn>2319-7692</issn>
<eissn>2319-7706</eissn>
<publicationDate>2015-12-20</publicationDate>
<volume>4</volume>
<issue>12</issue>
<startPage>434</startPage>
<endPage>440</endPage>
<documentType>article</documentType> 



<title language="eng">
Serum Leptin and Body Mass Index in Type 2 Diabetes Mellitus Patients of Dehradun, Uttarakhand, India
</title><authors>
			
			<author>
			<name>Anil Kumar</name>
			<affiliationId>1</affiliationId>
			</author>
			<author>
			<name>Sunny Chopra</name>
			<affiliationId>2</affiliationId>
			</author>
			<author>
			<name>Ashok Kumar Lal</name>
			<affiliationId>3</affiliationId>
			</author>
			
			
</authors>

<affiliationsList>
			<affiliationName affiliationId="1">
Department of Biochemistry, Teerthanker Mahaveer Medical College and Research Centre, Moradabad, U.P-244001, India
</affiliationName>
			<affiliationName affiliationId="2">
Department of Biochemistry, Gian sagar Medical College and Hospital, Banur, Rajpura, Patiala-147001, India</affiliationName>

			<affiliationName affiliationId="3">
Department of Biochemistry, Himalayan Institute of Medical Sciences, Jolly grant, Dehradun, India</affiliationName>

</affiliationsList>
<abstract language="eng">
			<p>The aim of this study was to evaluate the variation in serum leptin levels in obese and non-obese type 2 diabetes mellitus (type 2 DM) patients and compared them with normal healthy controls. The study group consisted of forty patients of type 2 DM and twenty normal healthy controls. Blood glucose (FBS and PPBS), HbA1c, Serum lipids and lipoproteins, Serum leptin, and Body mass index (BMI) were estimated in obese and non-obese type 2 DM patients and normal healthy controls. The Mean±SD of serum leptin levels were significantly higher in obese (9.83± 1.72 ng/ml) and non-obese (6.09±1.83 ng/ml) type 2DM patients than normal healthy controls (5.38±2.20 ng/ml). BMI was found to be significantly higher in obese and non-obese patients than controls (28.1 ± 1.1, 23.5 ± 3.4 and 22.8 ± 2.3 respectively). Serum lipid and lipoprotein levels were observed to be significantly raised in patients of type 2 DM.The study concluded increased leptin levels were significantly correlated with high BMI (obesity) and type 2 DM. Hence increased levels of serum leptin can be used as risk factor in the development of type 2 DM.</p>
</abstract>

<fullTextUrl format="pdf">
http://ijcmas.com/vol-4-12/Anil Kumar, et al.pdf
</fullTextUrl>


<keywords language="eng">
		<keyword> BMI</keyword></keywords>
<keywords language="eng">
		<keyword> Type 2 DM</keyword></keywords>

<keywords language="eng">
		<keyword> Leptin</keyword></keywords>
<keywords language="eng">
		<keyword> Obese</keyword></keywords>

<keywords language="eng">
		<keyword> Non-Obese</keyword></keywords>

<keywords language="eng">
		<keyword> HbA1c</keyword></keywords>

</record>
</records>